Author

Richard A. Lirio

ASSESSMENT OF VEDOLIZUMAB DISEASE-DRUG-DRUG INTERACTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
ASSESSMENT OF VEDOLIZUMAB DISEASE-DRUG-DRUG INTERACTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Richard A. Lirio  et al.

DISEASE CONTROL AND CHANGES IN INDIVIDUAL TREATMENT OUTCOMES FROM WEEK 14 TO WEEK 52 WITH VEDOLIZUMAB OR ADALIMUMAB IN ULCERATIVE COLITIS: A VARSITY TRIAL POST HOC ANALYSIS
DISEASE CONTROL AND CHANGES IN INDIVIDUAL TREATMENT OUTCOMES FROM WEEK 14 TO WEEK 52 WITH VEDOLIZUMAB OR ADALIMUMAB IN ULCERATIVE COLITIS: A VARSITY TRIAL POST HOC ANALYSIS

Richard A. Lirio  et al.

Item 1 - 2 / 2
1